Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity

समान संसाधन

• Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
  द्वारा: Su, Chia-Yu, और अन्य
  प्रकाशित: (2018)
• Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
  द्वारा: Lin, Wen-Wei, और अन्य
  प्रकाशित: (2021)
• Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
  द्वारा: Huang, Shuyu, और अन्य
  प्रकाशित: (2020)
• Dual targeting strategies with bispecific antibodies
  द्वारा: Kontermann, Roland E
  प्रकाशित: (2012)
• Bispecifics, trispecifics, and other novel immune treatments in myeloma
  द्वारा: Lancman, Guido, और अन्य
  प्रकाशित: (2020)